You searched for "ROP"
Long-term specular microscopy following Nd: YAG iridotomy in chronic POAG
The aim of this study was to evaluate specular microscopy of chronic primary angle-closure glaucoma (CPACG) eyes at least one year after Nd:YAG iridotomy, and compare them with CPACG eyes without an iridotomy and age-matched, normal eyes. Nd:YAG laser causes...
Fellow eye comparison of DMEK and PKP
This retrospective analysis of 11 patients who underwent penetrating keratoplasty (PKP) in their first eye followed by descemet membrane endothelial keratoplasty (DMEK) in their second eye studied visual and refractive outcomes. Intra and postoperative complications were compared and a subjective...
Adjuvant intravitreal dexamethasone implant for persistent CME
In this retrospective, cross-sectional study the authors investigate the efficiency of intravitreal dexamethasone implants (0.7mg) for cystoid macular oedema (CME) persisting, despite immunomodulatory treatment in patients with Behcets’ disease (BD). Twenty-seven eyes of 20 patients (12 males and eight females)...Rayner announces acquisition of Sophi
Rayner, a global leader in products for cataract surgery headquartered in Worthing, UK, announced today (17 January 2024) that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.Haag-Streit UK relaunches the Perkins Mk 3 hand-held applanation tonometer
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce that they have relaunched the Perkins Mk 3 hand-held applanation tonometer. Haag-Streit UK discontinued the...Oertli launches the OS 4 UpTM surgical platform along with new instruments for retina and cataract surgery
Berneck, 4th September 2025 – Oertli Instrumente AG presented its surgical platform, the OS 4 UpTM, to the attendees of the Euretina and ESCRS congresses. The platform introduces forward-thinking solutions for vitreoretinal and cataract surgery and is complemented by new...Glaukos Launches iStent infinite® in the UK Following MDR Approval
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...
